BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Techniques

Biomarkers

Hongjiang Li
August 16, 2017 5:43 PM UTC

Tumor levels of a panel of mRNA splice variants could help diagnose prostate cancer in African-Americans and levels of one PI3KCD variant could help predict survival. Transcriptomic analysis of tumor ...

BCIQ Company Profiles

The George Washington University

BCIQ Target Profiles

Fibroblast growth factor (FGF) receptor 3 (FGFR3) (CD333)

Phosphoinositide 3-kinase (PI3K) catalytic subunit delta polypeptide (PI3KCD) (P110delta)

RAS guanyl releasing protein 2 (RASGRP2)

BCIQ Company Profiles

The George Washington University

BCIQ Target Profiles

Fibroblast growth factor (FGF) receptor 3 (FGFR3) (CD333)

Phosphoinositide 3-kinase (PI3K) catalytic subunit delta polypeptide (PI3KCD) (P110delta)

RAS guanyl releasing protein 2 (RASGRP2)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS